Interferon beta (IFN-β) treatment exerts potential neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor 1 pathway

Por Wang, Qin, Mao-Draayer, Yang
Publicado no Neural Regen Res (2015)

Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE)

Por Hackett, Charles, Knight, Julia, Mao-Draayer, Yang
Publicado em 2014

Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis

Por Soltys, John, Wang, Qin, Mao-Draayer, Yang
Publicado no Neural Regen Res (2017)

Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse

Por Mills, Elizabeth A., Mirza, Ali, Mao-Draayer, Yang
Publicado no Front Neurol (2017)

Fas Activation Increases Neural progenitor Cell Survival

Por Knight, Julia C., Scharf, Eugene L., Mao-Draayer, Yang
Publicado no J Neurosci Res (2010)

The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases

Por Mao-Draayer, Yang, Sarazin, Jeffrey, Fox, David, Schiopu, Elena
Publicado no Clin Immunol (2016)

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

Por Du, Fanny Huynh, Mills, Elizabeth A., Mao-Draayer, Yang
Publicado no Auto Immun Highlights (2017)

IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection

Por Soltys, John, Knight, Julia, Scharf, Eugene, Pitt, David, Mao-Draayer, Yang
Publicado em 2014

Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) and Vasoactive Intestinal Peptide (VIP) Regulate Murine Neural Progenitor Cell Survival, Proliferation, and Differentiati...

Por Scharf, Eugene, May, Victor, Braas, Karen M., Shutz, Kristin C., Mao-Draayer, Yang
Publicado em 2008

The Effect of Interferon-β on Mouse Neural Progenitor Cell Survival and Differentiation

Por Hirsch, Marek, Knight, Julia, Tobita, Mari, Soltys, John, Panitch, Hillel, Mao-Draayer, Yang
Publicado no Biochem Biophys Res Commun (2009)

Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients

Por Wu, Qi, Wang, Qin, Mao, Guangmei, Dowling, Catherine A., Lundy, Steven K., Mao-Draayer, Yang
Publicado no J Immunol (2017)

Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment

Por Himedan, Mai, Camelo-Piragua, Sandra, Mills, Elizabeth A., Gupta, Avneesh, Aburashed, Rany, Mao-Draayer, Yang
Publicado no J Investig Med High Impact Case Rep (2017)

Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity

Por Cherian, Ajeesh Koshy, Parikh, Vinay, Wu, Qi, Mao-Draayer, Yang, Wang, Qin, Blakely, Randy D., Sarter, Martin
Publicado no Neurochem Int (2017)

Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets

Por Lundy, Steven K., Wu, Qi, Wang, Qin, Dowling, Catherine A., Taitano, Sophina H., Mao, Guangmei, Mao-Draayer, Yang
Publicado no Neurol Neuroimmunol Neuroinflamm (2016)

Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway

Por Wang, Qin, Chuikov, Sergei, Taitano, Sophina, Wu, Qi, Rastogi, Arjun, Tuck, Samuel J., Corey, Joseph M., Lundy, Steven K., Mao-Draayer, Yang
Publicado no Int J Mol Sci (2015)